As Canada’s cannabis industry stands at a pivotal crossroads, the impending departure of Prime Minister Justin Trudeau marks the end of an era that reshaped Canada’s relationship with the plant.
Trudeau’s bold decision to legalize recreational cannabis in 2018 not only transformed the nation’s social and economic landscape but also established it as a global pioneer in marijuana reform: Canada remains the only G7 nation to have federally legalized the plant both for medical and adult-use purposes.
The impact of cannabis legalization on Trudeau’s legacy is undeniable.
Recent polls indicate that 62% of Canadians support cannabis legalization, a testament to the policy’s enduring popularity and success.
In fact, when asked about Trudeau’s top accomplishments, the largest proportion of Canadians point to the legalization of recreational cannabis, according to a survey by Leger, a North American market research company based in Montreal.
The prospect of a Conservative Party government led by Pierre Poilievre raises concerns for the industry’s trajectory.
One of the most pressing issues is the potential downsizing of Health Canada’s Controlled Substances and Cannabis Branch.
This critical department, currently employing more than 200 staff members, plays a vital role in regulating and overseeing our industry.
A Conservative government focused on reducing federal spending could target this department for cuts, potentially creating bottlenecks in licensing processes, amendments and export license approvals.
TO CONTINUE READING: MJBIzDaily
Chargement en cours...
